Search research articles
Contact Us
Filters
Showing results (11-20 of 158) with videos related to
Page
of 16
Sort By:
Journal of Neurochemistry
|
February 1, 1973
Action of neuraminidase (EC 3.2.1.18) from Clostridium perfringens on brain gangliosides in the presence of bile salts
D A Wenger, S Wardell
The Journal of Biological Chemistry
|
November 15, 1986
Synthesis and processing of sphingolipid activator protein-2 (SAP-2) in cultured human fibroblasts
S Fujibayashi, D A Wenger
The Journal of Pediatrics
|
November 1, 1982
Prenatal diagnosis of Krabbe disease: galactosylceramide metabolism in cultured amniotic fluid cells
T Kudoh, D A Wenger
Physiological Chemistry and Physics
|
January 1, 1972
Action of neuraminidase from Clostridium perfringens of Tay-Sachs ganglioside
D A Wenger, S Wardell
Archives of Biochemistry and Biophysics
|
September 1, 1984
Biochemical, immunological, and structural studies on a sphingolipid activator protein (SAP-1)
K Inui, D A Wenger
The Journal of Pediatrics
|
December 1, 1994
Adult and infantile Gaucher disease in one family: mutational studies and clinical update
M Shahinfar, D A Wenger
Progress in Clinical and Biological Research
|
January 1, 1982
Homozygote and heterozygote identification
D A Wenger, S Roth
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
March 15, 1985
Studies on a sphingolipid activator protein (SAP-2) in fibroblasts from patients with lysosomal storage diseases, including Niemann-Pick disease Type C
S Fujibayashi, D A Wenger
Biochemical and Biophysical Research Communications
|
March 30, 1982
Properties of a protein activator of glycosphingolipid hydrolysis isolated from the liver of a patient with GM1 gangliosidosis, type 1
K Inui, D A Wenger
Developmental Neuroscience
|
January 1, 1991
Pseudodeficiencies of arylsulfatase A and galactocerebrosidase activities
D A Wenger, E Louie
Page
of 16
Search research articles
Search
Showing results (11-20 of 158) with videos related to
Sort By:
Page
of 16
Journal of Neurochemistry
|
February 1, 1973
Action of neuraminidase (EC 3.2.1.18) from Clostridium perfringens on brain gangliosides in the presence of bile salts
D A Wenger, S Wardell
The Journal of Biological Chemistry
|
November 15, 1986
Synthesis and processing of sphingolipid activator protein-2 (SAP-2) in cultured human fibroblasts
S Fujibayashi, D A Wenger
The Journal of Pediatrics
|
November 1, 1982
Prenatal diagnosis of Krabbe disease: galactosylceramide metabolism in cultured amniotic fluid cells
T Kudoh, D A Wenger
Physiological Chemistry and Physics
|
January 1, 1972
Action of neuraminidase from Clostridium perfringens of Tay-Sachs ganglioside
D A Wenger, S Wardell
Archives of Biochemistry and Biophysics
|
September 1, 1984
Biochemical, immunological, and structural studies on a sphingolipid activator protein (SAP-1)
K Inui, D A Wenger
The Journal of Pediatrics
|
December 1, 1994
Adult and infantile Gaucher disease in one family: mutational studies and clinical update
M Shahinfar, D A Wenger
Progress in Clinical and Biological Research
|
January 1, 1982
Homozygote and heterozygote identification
D A Wenger, S Roth
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
March 15, 1985
Studies on a sphingolipid activator protein (SAP-2) in fibroblasts from patients with lysosomal storage diseases, including Niemann-Pick disease Type C
S Fujibayashi, D A Wenger
Biochemical and Biophysical Research Communications
|
March 30, 1982
Properties of a protein activator of glycosphingolipid hydrolysis isolated from the liver of a patient with GM1 gangliosidosis, type 1
K Inui, D A Wenger
Developmental Neuroscience
|
January 1, 1991
Pseudodeficiencies of arylsulfatase A and galactocerebrosidase activities
D A Wenger, E Louie
Page
of 16